Back to Home
Free CE/CMEMultimedia

Burst CME Plus™ Module #1: Breaking the Demodex Blepharitis Cycle: The Importance of Early Intervention

Release Date

June 30, 2025

Expiration Date

July 1, 2026

Credits

0.25 COPE

Specialties

Optometry

Release Date: June 30, 2025

Expiration Date: June 30, 2026

Activity Overview

Blepharitis is an eye disease that is characterized by inflammation of the eyelid margin, redness, and ocular irritation. Among the many causes of blepharitis are Demodex mites, the most common ectoparasite found on human skin. Although blepharitis is common, Demodex as a causative organism is often overlooked. Studies have found that about 58% of patients presenting to eye clinics for any reason show signs of Demodex blepharitis; estimated cases in the US approach 25 million. Left undiagnosed, Demodex blepharitis can result in significant morbidity.

The purpose of this Burst CME continuing education program is to increase the knowledge of clinicians on the epidemiology of Demodex blepharitis. Dr Selina McGee also reviews the disease burden and impact of Demodex symptoms on patients’ quality of life.

Target Audience

This online educational activity is directed toward optometrists, ophthalmologists, and other eyecare professionals involved in the management of patients with Demodex blepharitis (DB).

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Summarize the disease burden in patients with Demodex blepharitis
Burst CME Plus™ Module #1: Breaking the Demodex Blepharitis Cycle: The Importance of Early Intervention

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC is accredited by COPE to provide continuing education to optometrists.

Physicians’ Education Resource®, LLC designates this activity for a maximum of 0.25 COPE credits.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Tarsus Pharmaceuticals, Inc.

Related Content

Course

Burst CME Plus™ Module #1: Breaking the Demodex Blepharitis Cycle: The Importance of Early Intervention

Create Account